biguanides has been researched along with Brain Inflammation in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martín-Pérez, T | 1 |
| Lozano-Cruz, T | 1 |
| Criado-Fornelio, A | 1 |
| Ortega, P | 1 |
| Gómez, R | 1 |
| de la Mata, FJ | 1 |
| Pérez-Serrano, J | 1 |
1 other study available for biguanides and Brain Inflammation
| Article | Year |
|---|---|
Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebicides; Animals; Biguanides; Cell Line, Tumor; Chlorhexidi | 2019 |